{"id":"W2518422528","doi":"10.1634/theoncologist.2016-0164","title":"Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer","year":2016,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Adverse effect; Tolerability; Lung cancer; Oncology; Chemotherapy; Immune system; Immunotherapy; Monoclonal antibody; Internal medicine; Intensive care medicine; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008018448,0.0003634028,0.001191132,0.0001268499,0.00006870634,0.000005505658,0.0002035789,0.0002903647,0.00002808568],"category_scores_gemma":[0.00001824515,0.0001804917,0.000252819,0.0004645463,0.0002266684,0.00003719659,0.000101975,0.0003485395,0.000001872993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001227645,"about_ca_system_score_gemma":0.0003126846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005806276,"about_ca_topic_score_gemma":0.00004821754,"domain_scores_codex":[0.998,0.0002121518,0.0008107115,0.0003339754,0.0002899627,0.0003531701],"domain_scores_gemma":[0.9985762,0.00009026571,0.0008762006,0.0003499468,0.00005429065,0.00005306184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0007513978,0.0003878333,0.004505367,0.01566779,0.002085956,0.0001074885,0.0001484718,4.772647e-7,0.00005875028,0.00000504222,0.00002423571,0.9762572],"study_design_scores_gemma":[0.02020069,0.002371151,0.03010202,0.6565387,0.007116034,0.00004399157,0.0004887935,0.00000637303,0.000484918,0.0000168586,0.2813655,0.001265006],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02167265,0.9717781,7.206149e-7,0.00008905067,0.0002233651,0.005379034,0.00002217142,0.00004161521,0.0007933099],"genre_scores_gemma":[0.01411615,0.9817603,0.00005525873,0.00000454344,0.00004746945,0.001314649,0.00001693943,0.00004985392,0.002634781],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9749922,"threshold_uncertainty_score":0.7360239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03120782614683579,"score_gpt":0.3414728858770757,"score_spread":0.3102650597302399,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}